Will Uwe, Reichel Andreas, Fueldner Frank, Meyer Frank
Uwe Will, Andreas Reichel, Frank Fueldner, Department of Internal Medicine III (Gastroenterology and Hepatology), Municipal Hospital (SRH Waldklinikum GmbH), 07548 Gera, Germany.
World J Gastroenterol. 2015 Dec 14;21(46):13140-51. doi: 10.3748/wjg.v21.i46.13140.
To evaluate the use of translumenal pancreatography with placement of endoscopic ultrasonography (EUS)-guided drainage of the pancreatic duct.
This study enrolled all consecutive patients between June 2002 and April 2014 who underwent EUS-guided pancreatography and subsequent placement of a drain and had symptomatic retention of fluid in the pancreatic duct after one or more previous unsuccessful attempts at endoscopic retrograde cannulation of the pancreatic duct. In all, 94 patients underwent 111 interventions with one of three different approaches: (1) EUS-endoscopic retrograde drainage with a rendezvous technique; (2) EUS-guided drainage of the pancreatic duct; and (3) EUS-guided, internal, antegrade drainage of the pancreatic duct.
The mean duration of the interventions was 21 min (range, 15-69 min). Mean patient age was 54 years (range, 28-87 years); the M:F sex ratio was 60:34. The technical success rate was 100%, achieving puncture of the pancreatic duct including pancreatography in 94/94 patients. In patients requiring drainage, initial placement of a drain was successful in 47/83 patients (56.6%). Of these, 26 patients underwent transgastric/transbulbar positioning of a stent for retrograde drainage; plastic prostheses were used in 11 and metal stents in 12. A ring drain (antegrade internal drainage) was placed in three of these 26 patients because of anastomotic stenosis after a previous surgical intervention. The remaining 21 patients with successful drain placement had transpapillary drains using the rendezvous technique; the majority (n = 19) received plastic prostheses, and only two received metal stents (covered self-expanding metal stents). The median follow-up time in the 21 patients with transpapillary drainage was 28 mo (range, 1-79 mo), while that of the 26 patients with successful transgastric/transduodenal drainage was 9.5 mo (range, 1-82 mo). Clinical success, as indicated by reduced or absence of further pain after the EUS-guided intervention was achieved in 68/83 patients (81.9%), including several who improved without drainage, but with manipulation of the access route.
EUS-guided drainage of the pancreatic duct is a safe, feasible alternative to endoscopic retrograde drainage when the papilla cannot be reached endoscopically or catheterized.
评估经腔胰管造影术联合内镜超声(EUS)引导下胰管引流的应用。
本研究纳入了2002年6月至2014年4月期间所有连续接受EUS引导下胰管造影术及后续引流管置入的患者,这些患者在先前一次或多次内镜逆行胰管插管尝试失败后,胰管内有症状性液体潴留。总共94例患者接受了111次干预,采用三种不同方法之一:(1)EUS-内镜逆行会师技术引流;(2)EUS引导下胰管引流;(3)EUS引导下胰管顺行内引流。
干预的平均持续时间为21分钟(范围15 - 69分钟)。患者平均年龄为54岁(范围28 - 87岁);男女比例为60:34。技术成功率为100%,94/94例患者实现了胰管穿刺包括胰管造影。在需要引流的患者中,83例患者中有47例(56.6%)首次引流管置入成功。其中,26例患者接受了经胃/经球囊支架逆行引流定位;11例使用塑料假体,12例使用金属支架。这26例患者中有3例因先前手术干预后吻合口狭窄而放置了环形引流管(顺行内引流)。其余21例引流管置入成功的患者采用会师技术进行经乳头引流;大多数(n = 19)接受塑料假体,仅2例接受金属支架(覆膜自膨式金属支架)。21例经乳头引流患者的中位随访时间为28个月(范围1 - 79个月),而26例经胃/经十二指肠引流成功患者的中位随访时间为9.5个月(范围1 - 82个月)。EUS引导干预后疼痛减轻或消失表明临床成功,83例患者中有68例(81.9%)实现了临床成功,包括几例未进行引流但通过操作进入路径而病情改善的患者。
当无法通过内镜到达乳头或进行插管时,EUS引导下胰管引流是内镜逆行引流的一种安全、可行的替代方法。